![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
GEN - Genetic Engineering and Biotechnology News
Get the latest news and information on genetic engineering and biotechnology including analysis, features, webinars, podcasts, and more.
2025 Trends: NGS
2025年1月6日 · A New Phase of Multiomic Analysis. Gordon Sanghera, PhD CEO Oxford Nanopore Technologies. I n 2025, population-scale genome studies will begin expanding to an …
Top 25 Biotech Companies of 2024 - genengnews.com
2024年1月12日 · However, biotechnology remains a profitable investment in the long term. Over the past five years, the market cap for the top 25 biotechnology companies soared nearly 78% …
Top 10 Biopharma Takeover Targets of 2024 - genengnews.com
2024年2月1日 · Viewed simply by numbers of merger and acquisition (M&A) deals, 2023 was a down year: 1,078 biotech companies found buyers last year, down from 1,088 in 2022, while …
The State of Cell and Gene Therapy 2025 - genengnews.com
2024年12月18日 · The field of cell and gene therapy has seen a wave of exciting advances in the past 12 months. Following the landmark approval of the first CRISPR-based cell therapy in …
“Suspended Animation” Technique for Blood Draws Designed to …
2025年1月6日 · Alex Heubeck, researcher at the Allen Institute for Immunology and lead author of the study, works with blood samples in the lab. [Allen Institute] “This technique allows you to, …
Top 10 Contract Development and Manufacturing Organizations
2023年9月15日 · GEN’s first-ever Top 10 A-List of contract developers and manufacturers is here. Of the top 10 companies listed, only three are headquartered in the U.S.; the rest are based in …
Major Trends in Cell and Gene Therapy - genengnews.com
2025年1月6日 · The emergence of new cell-line systems for AAV manufacturing such as packaging and producer lines brings the potential for increased process robustness and cost …
Top 10 Publicly Owned Gene Editing Therapy Companies
2024年5月31日 · But at prices exceeding $1 million, gene editing therapies have been administered to only 250 people. Institutions working to raise that number include the …
Recursion to Acquire Exscientia, Combining AI Drug Pioneers
2024年8月8日 · Two months earlier, Exscientia pruned its pipeline down to four active drug candidates in therapeutic areas that include inflammatory disease, hematology, and most …